Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F7ZVV
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $43,687
Award facts
- Contract value 100% obligated
- $43,686.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $43,686.80 to AmerisourceBergen Drug Corp for the supply of BIKTARVY 50-200-25 mg tablets in quantities of 30 units. The contract, awarded on January 18, 2026, is a firm fixed-price delivery order with an ultimate completion date of January 20, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive $999,999,999.00 vehicle valued through December 2026 that serves as the prime pharmaceutical supply contract for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing essential medical products to federal agencies, particularly the Department of Defense and veteran healthcare systems. The company's extensive contract portfolio demonstrates its capacity to supply diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This delivery order for BIKTARVY, an antiretroviral medication used in HIV treatment, exemplifies the critical role AmerisourceBergen plays in ensuring the Defense Health Agency and other federal healthcare systems maintain adequate pharmaceutical inventories to support military personnel and beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F7ZVV?
SPE2DR26F7ZVV was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 18, 2026.
How much is contract SPE2DR26F7ZVV worth?
The government has obligated $43,687 on SPE2DR26F7ZVV.
Is contract SPE2DR26F7ZVV an order under another contract?
Yes. SPE2DR26F7ZVV is a delivery order under SPE2DR25D7066, an indefinite delivery contract.
Was contract SPE2DR26F7ZVV competed?
The extent of competition for SPE2DR26F7ZVV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award